Request Trial
upc-image-aug-27
F. JIMENEZ MECA/shutterstock.com
4 April 2023FeaturesAmericasChristopher Sharp, Sarah Taylor, Robert Greene Sterne and Nirav Desai

Why the UPC will be rewarding for US businesses

Patents are presently enforced and challenged in Europe on a country-by-country basis. National decisions may be inconsistent, relief is confined to smaller markets, and—compared with US patent litigation—the potential for large damages awards is limited.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Insulin pump rivals face off in major trade secrets dispute hearing
8 January 2026   Important questions about when companies must act on suspicions of theft and whether damages can stack with injunctions were raised in a dispute that has already sent ripples across med tech.
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026   Crop science division alleges that vaccine developers used patented mRNA stability technology in shots that earned them around $140 billion in global sales.
Americas
Merchant & Gould hires 13 attorneys to open new Boston office
6 January 2026   The new recruits from a boutique Boston firm enables Merchant to expand and strengthen its tech and life sciences offering in the innovation hub.


Editor's picks

Bayer enters COVID-19 vaccine row with three suits against major drugmakers
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026

Editor's picks

Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

Insulin pump rivals face off in major trade secrets dispute hearing
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
Who are the world’s best in-house counsel? Final call for the leading corporate IP professionals
Merchant & Gould hires 13 attorneys to open new Boston office
Key EU and UK regulatory changes to watch for in 2026
PTAB year in review: A shifting landscape and outlook for 2026
UPC: A review of 2025 and what to expect in 2026
From Edwards to Insulet: Three key medical device cases of 2025